A Vaccine to Prevent Congenital Cytomegalovirus

This Viewpoint discusses progress toward the development of a preconception vaccine for congenital cytomegalovirus, which could reduce the prevalence and severity of infection.

Corresponding Author: Mark R. Schleiss, MD, Division of Pediatric Infectious Diseases and Immunology, University of Minnesota, 2001 6th St SE, Minneapolis, MN 55455 (schleiss@umn.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.